The integration of Artificial Intelligence (AI) into oncology holds transformative potential for diagnostics, treatment personalization, and drug discovery.
The integration of hybrid deep learning (DL) architectures is revolutionizing genomic analysis, offering unprecedented accuracy in variant calling, tumor subtyping, and biomarker discovery.
This article provides a comprehensive overview of advanced computational strategies for extracting meaningful features from high-dimensional genomic data to improve cancer classification.
This article provides a comprehensive overview of signal processing (SP) methodologies for identifying cancerous patterns in DNA sequences.
This article provides a comprehensive analysis of circulating tumor DNA (ctDNA) fraction, a critical biomarker in early-stage cancer.
This article provides a comparative analysis of structure-based and ligand-based pharmacophore modeling, two pivotal computational strategies in modern drug discovery.
Ligand-based pharmacophore modeling is a cornerstone of computer-aided drug design, particularly for targets with unknown 3D structures.
This article provides a comprehensive comparison of pharmacophore-based virtual screening (PBVS) and docking-based virtual screening (DBVS) for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing pharmacophore feature selection and weighting, a critical step for enhancing virtual screening success and designing selective...
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of validating pharmacophore models using decoy sets.